In patients who are at risk of developing ulcer complications and whose arthritis cannot be relieved by simple analgesics, combination therapy with NSAIDs and a gastroprotective agent has ...
Daewoong Pharmaceutical said on the 1st it launched P-CAB class gastrointestinal drug Pexuclu 20 mg (ingredient name fexuprazan hydrochloride), the first in Korea to be officially recognized for ...
HK inno.N said on the 22nd that its gastroesophageal reflux disease treatment "K-CAB" is effective in preventing gastric and duodenal ulcers. It noted that when nonsteroidal anti-inflammatory drugs ...
BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced the presentation of preclinical data at Digestive Disease Week 2012, in San Diego, which demonstrates the ...
Ian Musgrave receives funding from the National Health and Medical Research Council to study adulterants and contaminants of herbal medicines, and has received past funding from the Australian ...
Despite the availability of potent gastroprotective agents and gastric-sparing NSAIDs, hospitalization due to NSAID-related gastrointestinal complications remains an important problem, particularly ...